181 related articles for article (PubMed ID: 20134275)
1. Subcutaneous methylnaltrexone to restore postoperative bowel function in a long-term opiate user.
Ladanyi A; Temkin SM; Moss J
Int J Gynecol Cancer; 2010 Feb; 20(2):308-10. PubMed ID: 20134275
[TBL] [Abstract][Full Text] [Related]
2. Off-label uses of alvimopan and methylnaltrexone.
Rodriguez RW
Am J Health Syst Pharm; 2014 Sep; 71(17):1450-5. PubMed ID: 25147168
[TBL] [Abstract][Full Text] [Related]
3. Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus.
Neyens R; Jackson KC
J Pain Palliat Care Pharmacother; 2007; 21(2):27-33. PubMed ID: 17844725
[TBL] [Abstract][Full Text] [Related]
4. Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus.
Becker G; Blum HE
Lancet; 2009 Apr; 373(9670):1198-206. PubMed ID: 19217656
[TBL] [Abstract][Full Text] [Related]
5. The Efficacy and Safety of Methylnaltrexone for the Treatment of Postoperative Ileus.
Beavers J; Orton L; Atchison L; Medvecz A; Dennis B; Guillamondegui O; Smith MC
Am Surg; 2022 Mar; 88(3):409-413. PubMed ID: 34645328
[TBL] [Abstract][Full Text] [Related]
6. Methylnaltrexone: MNTX.
Drugs R D; 2006; 7(6):374-8. PubMed ID: 17073520
[TBL] [Abstract][Full Text] [Related]
7. Methylnaltrexone Versus Naloxone for Opioid-Induced Constipation in the Medical Intensive Care Unit.
Merchan C; Altshuler D; Papadopoulos J
Ann Pharmacother; 2017 Mar; 51(3):203-208. PubMed ID: 28168885
[TBL] [Abstract][Full Text] [Related]
8. Methylnaltrexone bromide: new drug for the treatment of opioid-induced bowel dysfunction.
Baker DE
Rev Gastroenterol Disord; 2009; 9(3):E84-93. PubMed ID: 19898269
[TBL] [Abstract][Full Text] [Related]
9. Methylnaltrexone: a subcutaneous treatment for opioid-induced constipation in palliative care patients.
Kyle G
Int J Palliat Nurs; 2009 Nov; 15(11):533-40. PubMed ID: 20081727
[TBL] [Abstract][Full Text] [Related]
10. A review of methylnaltrexone, a peripheral opioid receptor antagonist, and its role in opioid-induced constipation.
Shaiova L; Rim F; Friedman D; Jahdi M
Palliat Support Care; 2007 Jun; 5(2):161-6. PubMed ID: 17578067
[TBL] [Abstract][Full Text] [Related]
11. Use of methylnaltrexone for the treatment of opioid-induced constipation in critical care patients.
Sawh SB; Selvaraj IP; Danga A; Cotton AL; Moss J; Patel PB
Mayo Clin Proc; 2012 Mar; 87(3):255-9. PubMed ID: 22386181
[TBL] [Abstract][Full Text] [Related]
12. Methylnaltrexone: a novel approach for the management of opioid-induced constipation in patients with advanced illness.
Diego L; Atayee R; Helmons P; von Gunten CF
Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):473-85. PubMed ID: 19817669
[TBL] [Abstract][Full Text] [Related]
13. Methylnaltrexone: treatment for opioid-induced constipation.
Licup N; Baumrucker SJ
Am J Hosp Palliat Care; 2011 Feb; 28(1):59-61. PubMed ID: 20801917
[TBL] [Abstract][Full Text] [Related]
14. Methylnaltrexone for opioid-induced constipation.
Belavic JM
Nurse Pract; 2009 Mar; 34(3):6-7. PubMed ID: 19240629
[No Abstract] [Full Text] [Related]
15. A review of the potential role of methylnaltrexone in opioid bowel dysfunction.
Foss JF
Am J Surg; 2001 Nov; 182(5A Suppl):19S-26S. PubMed ID: 11755893
[TBL] [Abstract][Full Text] [Related]
16. Methylnaltrexone, a new peripheral mu-receptor antagonist for the prevention and treatment of opioid-induced extracerebral side effects.
Reichle FM; Conzen PF
Curr Opin Investig Drugs; 2008 Jan; 9(1):90-100. PubMed ID: 18183536
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of methylnaltrexone in shortening the duration of postoperative ileus following segmental colectomy: results of two randomized, placebo-controlled phase 3 trials.
Yu CS; Chun HK; Stambler N; Carpenito J; Schulman S; Tzanis E; Randazzo B
Dis Colon Rectum; 2011 May; 54(5):570-8. PubMed ID: 21471758
[TBL] [Abstract][Full Text] [Related]
18. Methylnaltrexone bromide for the treatment of opioid-induced constipation in patients with advanced illness--a cost-effectiveness analysis.
Earnshaw SR; Klok RM; Iyer S; McDade C
Aliment Pharmacol Ther; 2010 Apr; 31(8):911-21. PubMed ID: 20096019
[TBL] [Abstract][Full Text] [Related]
19. Reversal of opioid-induced gastric dysfunction in a critically ill burn patient after methylnaltrexone.
Woo M; O'Connor M; Yuan CS; Moss J
Anesth Analg; 2008 Dec; 107(6):1965-7. PubMed ID: 19020145
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Safety and Efficacy of Subcutaneous Methylnaltrexone in Patients with Opioid-Induced Constipation and Chronic Noncancer Pain: A Phase 3, Open-Label Trial.
Webster LR; Michna E; Khan A; Israel RJ; Harper JR
Pain Med; 2017 Aug; 18(8):1496-1504. PubMed ID: 28810695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
